abstract |
The invention relates to novel methods of using 2α-methyl-19-nor-20(S)-lα,25-dihydroxyvitamin D 3 or 2-methylene-19-nor-20(S)-l,25-dihydroxyvitamin D 3 to prevent Type 1 diabetes in a subject at risk of developing Type 1 diabetes without causing hypercalcemia in the subject. |